The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Golembiewski Michael Joseph since 2023.
This trader's CIK number is 1639479.
At the time of last reporting, Golembiewski Michael Joseph was the Chief Financial Officer of Seelos Therapeutics, Inc.. (stock ticker symbol SEEL).
Also see all insider trading activities at Seelos Therapeutics, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2023 | SEEL | 83,000 | $100,264 | 0 | $0 | 0 | $0 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2023-11-30 | SEEL | Buy | 83,000 | 1.21 | 100,264 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Golembiewski Michael Joseph (Chief Financial Officer of Seelos Therapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.